An alternative way to initiate Notch1 signaling in non-small cell lung cancer

Por Yang, Yi-Lin, Jablons, David, You, Liang
Publicado no Transl Lung Cancer Res (2014)

Is surgery still the optimal treatment for stage I non-small cell lung cancer?

Por Moghanaki, Drew, Chang, Joe Y.
Publicado no Transl Lung Cancer Res (2016)

A rare case of palatin tonsillar metastasis from small cell lung cancer

Por D’Antonio, Chiara, Lombardini, Alberto, Onesti, Concetta Elisa, Falcone, Rosa, Romiti, Adriana, Lombardi, Marianna, Lauro, Salvatore, Marchetti, Paolo
Publicado no Transl Lung Cancer Res (2016)

Targeted therapy for non-small cell lung cancer: current standards and the promise of the future

Por Chan, Bryan A., Hughes, Brett G.M.
Publicado no Transl Lung Cancer Res (2015)

Tumor mutational burden in non-small cell lung cancer—the pathologist’s point of view

Por Penault-Llorca, Frédérique, Radosevic-Robin, Nina
Publicado no Transl Lung Cancer Res (2018)

Angiogenesis and lung cancer: ramucirumab prolongs survival in 2(nd)-line metastatic NSCLC

Por Das, Millie, Wakelee, Heather
Publicado no Transl Lung Cancer Res (2014)

Volume versus diameter assessment of small pulmonary nodules in CT lung cancer screening

Por Han, Daiwei, Heuvelmans, Marjolein A., Oudkerk, Matthijs
Publicado no Transl Lung Cancer Res (2017)

Considerations when treating lung cancer with passive scatter or active scanning proton therapy

Por St. James, Sara, Grassberger, Clemens, Lu, Hsiao-Ming
Publicado no Transl Lung Cancer Res (2018)

Proton therapy for post-operative radiation therapy of non-small cell lung cancer

Por Shepherd, Annemarie Fernandes
Publicado no Transl Lung Cancer Res (2018)

Lung cancer diagnosis and staging in the minimally invasive age with increasing demands for tissue analysis

Por Folch, Erik, Costa, Daniel B., Wright, Jeffrey, VanderLaan, Paul A.
Publicado no Transl Lung Cancer Res (2015)

Overexpression of GOLPH3 is associated with poor survival in Non-small-cell lung cancer

Por Tang, Wanfen, Han, Mengjiao, Ruan, Beihong, Jin, Wei, Lou, Jun, Yuan, Xiamei, Chen, Dingwei, Chen, Yangchao, Shin, Vivian Y, Jin, Hongchuan, Wang, Xian
Publicado no Am J Transl Res (2016)

Peptide nucleic acids targeting mitochondria enhances sensitivity of lung cancer cells to chemotherapy

Por Chen, Sheng-Song, Tu, Xiao-Yun, Xie, Li-Xia, Xiong, Lv-Ping, Song, Juan, Ye, Xiao-Qun
Publicado no Am J Transl Res (2018)

Circulating soluble intercellular adhesion molecule-1 in lung cancer: a systematic review

Por Gu, Xiaoling, Ma, Chunyan, Yuan, Dongmei, Song, Yong
Publicado no Transl Lung Cancer Res (2012)

Immunotherapy in locally-advanced non-small cell lung cancer: releasing the brakes on consolidation?

Por Berman, Abigail T., Simone, Charles B.
Publicado no Transl Lung Cancer Res (2016)

Angiogenesis inhibition as a therapeutic strategy in non-small cell lung cancer (NSCLC)

Por Hall, Richard D., Le, Tri M., Haggstrom, Daniel E., Gentzler, Ryan D.
Publicado no Transl Lung Cancer Res (2015)

Clinical utility of circulating tumor cells in patients with non-small-cell lung cancer

Por Gallo, Marianna, De Luca, Antonella, Maiello, Monica Rosaria, D’Alessio, Amelia, Esposito, Claudia, Chicchinelli, Nicoletta, Forgione, Laura, Piccirillo, Maria Carmela, Rocco, Gaetano, Morabito, Alessandro, Botti, Gerardo, Normanno, Nicola
Publicado no Transl Lung Cancer Res (2017)

ALK and ROS1 as a joint target for the treatment of lung cancer: a review

Por Puig de la Bellacasa, Raimon, Karachaliou, Niki, Estrada-Tejedor, Roger, Teixidó, Jordi, Costa, Carlota, Borrell, José I.
Publicado no Transl Lung Cancer Res (2013)

Predictive models for customizing chemotherapy in advanced non-small cell lung cancer (NSCLC)

Por Bonanno, Laura
Publicado no Transl Lung Cancer Res (2013)

Nestin servers as a promising prognostic biomarker in non-small cell lung cancer

Por Liu, Fang, Zhang, Yuan, Lu, Ming, Wang, Cong, Li, Qingbao, Gao, Yongsheng, Mu, Dianbin, Cao, Yan, Li, Miaomiao, Meng, Xiangjiao
Publicado no Am J Transl Res (2017)

A consensus on immunotherapy from the 2017 Chinese Lung Cancer Summit expert panel

Por Wu, Yi-Long, Wang, Chang-Li, Liao, Mei-Lin, Guan, Zhong-Zhen, Gao, Chen-Yan, Lu, Shun, Zhao, Ming-Fang, Wang, Jie, Liu, Xiao-Qing, Yang, Jin-Ji, Liang, Jun, Mao, Wei-Min, Han, Bao-Hui, Zhang, Xu-Chao, Song, Yong, Feng, Ji-Feng, Ma, Sheng-Lin, Wu, Gang, Zhou, Cai-Cun, Chen, Ke-Neng, Cheng, Ying, He, Yong, Chen, Chun, Wang, Qun, Lin, Ji-Zhen, Zhu, Bo, Liu, Yun-Peng, Hu, Yi, Qiao, Gui-Bin, Zhou, Qing, Song, Qi-Bin, Wu, Nan, Wu, Lin, Huang, Cheng, Fu, Xiao-Long, Xiong, Jian-Ping, Hu, Jie, Hu, Cheng-Ping, Chang, Jian-Hua, Zhao, Qiong, Zhao, Jun, Zhou, Peng-Hui, Ma, Zhi-Yong, Chen, Yuan, Zhang, He-Long, Yang, Fan, Wang, Jian-Jun, Pan, Yue-Yin, Yang, Xue-Ning, Fan, Yun, Liu, Zhe, Fan, Wen, Yang, Nong, Guan, Yan-Fang, Sun, Hao, Zhong, Wen-Zhao
Publicado no Transl Lung Cancer Res (2018)